<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28">
 <label>28.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coler</surname>
    <given-names>RN</given-names>
   </name>
   <name>
    <surname>Duthie</surname>
    <given-names>MS</given-names>
   </name>
   <name>
    <surname>Hofmeyer</surname>
    <given-names>KA</given-names>
   </name>
   <name>
    <surname>Guderian</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Jayashankar</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Vergara</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE</article-title>. 
  <source>Clin Transl Immunol.</source> (
  <year>2015</year>) 
  <volume>4</volume>:
  <fpage>e35</fpage>. 
  <pub-id pub-id-type="doi">10.1038/cti.2015.6</pub-id>
  <?supplied-pmid 26175894?>
  <pub-id pub-id-type="pmid">26175894</pub-id>
 </mixed-citation>
</ref>
